Metraipolis › archive › dc_239e76eba070

A Phase III Clinical Trial of Immunogenicity and Safety of Meningococcal A and C Polysaccharide Conjugate Vaccine in Infants Aged 3-5 Months — Europe PMC PMID:41150410

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41150410
DOI
10.3390/vaccines13101023
License (as archived)
solo-consultazione
Archived
2026-11-09T16:57:57.969Z
SHA-256 of the archived text
d05208045551bc5af6ce666b9d20ce631a0d188982560dd4b34fccbea2808007
Stable URL of this page
https://metraipolis.com/documento/dc_239e76eba070

How to cite

A Phase III Clinical Trial of Immunogenicity and Safety of Meningococcal A and C Polysaccharide Conjugate Vaccine in Infants Aged 3-5 Months — Europe PMC PMID:41150410 — Europe PMC (en), https://europepmc.org/article/MED/41150410 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_239e76eba070 (Metraipolis archive dc_239e76eba070, sha256 d05208045551bc5af6ce666b9d20ce631a0d188982560dd4b34fccbea2808007)
BibTeX
@misc{dc239e76eba070,
  title = {A Phase III Clinical Trial of Immunogenicity and Safety of Meningococcal A and C Polysaccharide Conjugate Vaccine in Infants Aged 3-5 Months — Europe PMC PMID:41150410},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41150410},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_239e76eba070; sha256 d05208045551bc5af6ce666b9d20ce631a0d188982560dd4b34fccbea2808007},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41150410. Agents can read the archived copy with the MCP tool read_document.